Label: MAGNESIUM OXIDE tablet
- NDC Code(s): 84447-001-12
- Packager: Belleview Biosciences
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated April 1, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- DRUG FACTS
- Uses
-
Warnings
Ask a doctor before use if:
* you have kidney disease
* you are taking a prescription drug (antacids may interact with certain prescription drugs)
* you are pregnant or breast feeding
- Dosage and Administration
- Other Information
- INACTIVE INGREDIENT
- Questions of Comments?
- NDC 84447-001-12
-
INGREDIENTS AND APPEARANCE
MAGNESIUM OXIDE
magnesium oxide tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:84447-001 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CATION 241.3 mg in 1000 mg Inactive Ingredients Ingredient Name Strength SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) STEARIC ACID (UNII: 4ELV7Z65AP) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) Product Characteristics Color white (White to Off-White) Score score with uneven pieces Shape ROUND (Tablet) Size 4mm Flavor Imprint Code MG Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:84447-001-12 120 mg in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 04/01/2025 
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M001 04/01/2023 Labeler - Belleview Biosciences (131968803) Registrant - Belleview Biosciences (131968803) Establishment Name Address ID/FEI Business Operations Belleview Biosciences 131968803 manufacture(84447-001) , analysis(84447-001) , label(84447-001)

